The safety of citalopram was evaluated with adverse reaction scale and ECG.
采用副反应量表及心电图评估西酞普兰的安全性。
The patients were treated with the antidepressant citalopram for at least six weeks.
患者使用抗抑郁药物、西酞普兰至少六周。
Objective To explore the clinical effect and safety of citalopram in the treatment of aged depression.
目的探讨西酞普兰治疗老年抑郁症的疗效及安全性。
The benefits of citalopram also extended to perceived social support and daily function, the team notes.
研究小组说道，西酞普兰的优点还包括社会的认同和每天的功能。
Objective To determine the efficacy and safety of citalopram in the treatment of patients with depression.
目的探讨选择性五羟色胺再摄取抑制剂西酞普兰治疗抑郁症的疗效及安全性。
Objective: To study the effect of Trimebutine and Citalopram in the treatment of functional dyspepsia (FD).
目的：观察曲美布汀加喜普妙治疗功能性消化不良的疗效。
Objective To evaluate the curative effects and adverse reactions of citalopram in first-episode depression.
目的评价西酞普兰治疗首发抑郁症的疗效与不良反应。
Conclusion: Citalopram has good clinical effects and compliance in the treatment of generalized anxiety disorder.
结论：西酞普兰治疗广泛性焦虑疗效肯定，依从性好。
Objective To compare the effect and side-effect of citalopram and capsule of Wuling in treating senile depression.
目的比较单用西酞普和西酞普兰加乌灵胶囊对老年抑郁障碍的疗效和不良反应。
Objective To explore the curative effects and safety of citalopram in children with depression and emotional disorder.
目的观察西酞普兰治疗儿童抑郁和情绪障碍的疗效及安全性。
Objetive: To observe the curative effect of treating Depressive with anxiety by combination of Citalopram and Deanxit.
目的：观察西酞普兰合用黛力新治疗伴有焦虑症状的抑郁症的疗效。
The results of the study showed that women who used bupropion and citalopram or escitalopram all reduced their smoking.
研究结果表明使用安非他酮和西酞普兰或者依他普仑的女性均较少了她们的吸烟量。
Objective: To compare the efficacy and safety of citalopram and fluoxetine in the treatment of senile depressive disorder.
目的：比较西酞普兰和氟西汀治疗老年期抑郁障碍的疗效和安全性。
Objective: To compare the efficacy and safety of citalopram and amitriptyline in the treatment of patients with depression.
目的比较西酞普兰与阿米替林治疗抑郁症的疗效与副反应。
Objective to investigate the efficacy of citalopram combined with olanzapine in the treatment of depression with somatic symptoms.
目的探讨西酞普兰合并奥氮平对伴有躯体症状抑郁症的治疗效果。
First, amylose was selected as chiral selector and the enantiomeric separation of citalopram enantiomers was achieved successfully.
首先以可溶性淀粉这种多糖作为手性选择剂，成功实现了西酞普兰对映体的手性分离。
Over the 12 weeks of treatment, citalopram proved to be superior to placebo, with an average 3.3-point greater reduction in HAM-D scores.
在12周的治疗期间，西酞普兰被证明要好于安慰剂，在汉密顿抑郁量表的得分上要比其低3.3个百分点。
Objective: To compare the efficacy and safety of treatment of female depression disorder between Venlafaxine Sustained-Release and Citalopram.
目的：比较文拉法新缓释片与西酞普兰治疗女性抑郁症的疗效与安全性。
Objective To observe the clinical efficacy and side effects of Citalopram and Amitriptyline in the treatment of depression patients in old age.
目的比较喜普妙与阿米替林治疗老年期抑郁症的疗效及副反应。
Objective To compare the efficacy and security of citalopram and clomipramine in the treatment of depression, anxiety in cervical disc herniation patients.
目的比较西酞普兰与氯丙咪嗪治疗颈椎间盘突出症伴抑郁焦虑症状的疗效和不良反应。
Objective To investigate the efficacy and safety of citalopram in patients with chronic heart failure (CHF) complicated with depression with or without anxiety.
目的探讨西酞普兰对慢性心力衰竭(CHF)合并抑郁伴或不伴焦虑患者的有效性和安全性。
Results Both citalopram and f uxitine had clear curative effects, the effective rates were 95. 32% and 93. 49% respectively, which showed no significant difference .
结果西酞普兰与氟西汀对首发抑郁症均有确切的疗效，西酞普兰有效率95.32%，氟西汀有效率93.49%，两组疗效无显著性差异。
The response rate, defined as a 50% or greater reduction in HAM-D scores, was higher among patients receiving citalopram, at 35.9% compared with 22.5% for those given placebo.
反应率，定义为在汉密顿抑郁量表的得分上有50%或者更多的减少，要高于那些接受西酞普兰治疗的病人，其结果是35.9%比上22.5%，对于那些给予安慰剂的病人来说。
Objective: To observe the curative effectiveness of citalopram combined with cognitive therapy in the treatment of patients with somatization disorder and the effect of compliance.
目的：观察西酞普兰合并认知治疗对躯体化障碍患者的疗效及依从性。
Nor were there significant differences in the risk of suicidal ACTS within the SSRI drug class in the comparisons among citalopram, fluvoxamine, paroxetine, sertraline, and fluoxetine.
同样，这种自杀行为的风险差异也未表现在SSRIs类药物之间：西酞普兰、氟伏沙明、帕罗西汀、舍曲林和氟西汀。
Methods 30 depression patients were treated with citalopram and other 30 patients with armitpriptyline. The effect and side effects were assessed with HAMD and TESS, and the cost was contrasted.
方法采用HA MD和TESS，对30例服用西酞普兰和30例服用阿米替林的抑郁症患者的疗效和副反应进行比较，并对其费用进行比较分析。
Methods 30 depression patients were treated with citalopram and other 30 patients with armitpriptyline. The effect and side effects were assessed with HAMD and TESS, and the cost was contrasted.
方法采用HA MD和TESS，对30例服用西酞普兰和30例服用阿米替林的抑郁症患者的疗效和副反应进行比较，并对其费用进行比较分析。
应用推荐